Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy

Table 5 Comparison of FIB-4 index between complete virological response and partial virological response groups from baseline to 144 wk

	HBeAg-positive (n = 178)			HBeAg-negative (n = 53)
	CVR (n = 71)	PVR (n value = 107)	P value	CVR (n = 48)	PVR (n = 5)	P value
0 wk	1.89 ± 1.43	1.18 ± 0.69	< 0.001	2.17 ± 1.44	1.92 ± 1.66	0.71
48wk	1.20 ± 0.81	0.94 ± 0.57	0.007	1.50 ± 0.89	1.52 ± 0.82	0.79
144 wk	1.24 ± 0.87	1.02 ± 0.73	0.06	1.49 ± 0.90	1.12 ± 0.44	0.37
48-144 wk	-0.11 ± 0.47	-0.13 ± 0.49	0.71	-0.02 ± 0.34	-0.07 ± 0.38	0.44
0-144 wk	0.64 ± 1.25	0.15 ± 0.72	0.004	0.68 ± 0.95	0.81 ± 1.25	0.79

HBeAg: Hepatitis B e antigen; CVR: Complete virological response; PVR: Partial virological response.